support@dailyagronews.com      +91-8484924178

Mirati Names Synthorx’s Joseph Leveque as New Chief Medical Officer

Mirati Names Synthorx’s Joseph Leveque as New Chief Medical Officer
By: biot11 Posted On: May 19, 2020 View: 13

Mirati Names Synthorx’s Joseph Leveque as New Chief Medical Officer

Xconomy San Diego — 

Mirati Therapeutics (NASDAQ: MRTX) this week appointed Joseph Leveque as its new chief medical officer. Leveque most recently served as CMO at San Diego’s Synthorx, which was recently acquired by Sanofi. Prior he served in the same role at ARMO Biosciences, which was acquired by Eli Lilly (NYSE: LLY) in 2018. Previous experience includes positions at Merck KGaA subsidiary EMD Serono, Bristol-Myers Squibb (NYSE: BMS), Onyx Pharmaceuticals, Cephalon Oncology, and Amgen (NASDAQ: AMGN).

Leveque succeeds Isan Chen, who is stepping down from his role as chief medical and development officer at the San Diego-based cancer drug developer to lead an early-stage biotech company, according to Mirati. Chen, who was with Mirati for seven years, will continue to act as an advisor to the firm. Mirati’s lead drug candidate sitravatinib is under evaluation in combination with a checkpoint inhibitor in a Phase 3 trial for patients with non-small cell lung cancer.

Sarah de Crescenzo is an Xconomy editor based in San Diego. You can reach her at sdecrescenzo@xconomy.com. Follow @sarahdc

Trending on Xconomy

  Contact Us
  Dailyagronews.com.

Botawala Chambers , Fort-Mumbai

Tel : + (91) - 8484924178
Mail : support@dailyagronews.com
Business Hours : 9:30 - 5:30

  About

Dailyagronews is a dedicated platform for Exclusive Agriculture News , Now stay in touch with latest happenings in Agriculture . This site is a work of team of technocrafts wanted to help the farming community by contributing something helpful to them. Join this unique platform by contributing the agro news , we will be happy to make it viral